Emerging research suggests that 4FMA, a novel copyright compound, might hold promising potential for therapeutic applications. While still in its early stages, studies have shown that 4FMA can generate intense copyright experiences, arguably rivaling those of more recognized psychedelics like LSD and copyright. Researchers are currently exploring